tablets Valsakor are shown at:

• Arterial hypertension (tablet of 80 mg, 160 mg and 320 mg).
Treatment of arterial hypertension at adults and children 6 years are more senior than
• .
• Arterial hypertension (tablets of 40 mg).
• Treatment of arterial hypertension at children of 6 years.
• Postinfarction state (tablets of 40 mg, 80 mg and 160 mg).
• Treatment of clinically stable patients with symptomatic heart failure or symptomless systolic dysfunction of a left ventricle after recently postponed, a myocardial infarction.
• Heart failure (tablet of 40 mg, 80 mg and 160 mg).
• Treatment of symptomatic heart failure when it is impossible to apply APF (APF) inhibitors, or as additional therapy to intake of APF inhibitors when it is impossible to apply β-blockers.

Structure

Active ingredient: 1 tablet, coated, contains 40 mg or 80 mg, 160 mg, or 320 mg of a valsartan;

Excipients: lactose, cellulose microcrystalline, povidone, sodium of a kroskarmelloz, silicon dioxide colloidal, magnesium stearate, a gipromelloz, the titan dioxide (E 171), a macrogoal 4000, ferrous oxide yellow (E 172) - is available in tablets, coated, on 40 mg, 160 mg and 320 mg, ferrous oxide red (E 172) - is available in tablets, coated 80 mg, 160 mg and 320 mg.

Contraindication

Hypersensitivity to active agent or to any of medicament components the heavy abnormal liver functions, biliary cirrhosis and a cholestasia, pregnant women or women who are going to become pregnant; simultaneous use of antagonists of receptors of angiotensin, including valsartan, or APF inhibitors with aliskireny to patients with diabetes or a renal failure.

Valsakor® to accept

irrespective of meal, washing down with water.

to

Feature of use

Pregnant

It is contraindicated.

Valsartan to apply

to treatment of arterial hypertension at children of 6 years.

Drivers

As well as at intake of other antihypertensive drugs, it is desirable to be careful at control of motor transport or work with mechanisms owing to possible developing of dizziness or weakness.

Overdose

Symptoms. The overdose valsartany can lead to the profound arterial hypotension that can lead to oppression of consciousness, vascular collapse and/or shock.

Treatment. Therapeutic actions depend on time of reception and type and weight of symptoms. The major is stabilization of a condition of blood circulation. In arterial hypotension of the patient it is necessary to place in a prone position and to carry out adjustment of volume of blood.

that medicament can be removed by means of a hemodialysis.

Side effects

At patients with arterial hypertension the general frequency of side reactions is according to pharmacology of a valsartan. It turned out that the frequency of emergence of side reactions is not connected with a dose or duration of treatment and does not depend on a sex, age or race.

Interaction

easing of antihypertensive effect. Moreover, the accompanying reception of antagonists of angiotensin II and NPVP can lead to deterioration in function of kidneys and level of potassium in blood serum. Therefore it is recommended to control function of kidneys in an initiation of treatment and also adequate providing the patient with liquid.

to Store

at a temperature not above 30 °C in original packing for protection against moisture influence.

to Store

out of children's reach.

Expiration date - 5 years.